Primary study · included by 1 review

Higher overall survival rates of oral squamous cell carcinoma treated with metronomic neoadjuvant chemotherapy.

Kina 2024 · Kina Shinichiro, Miyamoto Sho, Kawabata-Iwakawa Reika, et al. · American journal of cancer research · 2024

Included by

Two-year follow-up outcomes of neoadjuvant therapy in oral squamous cell carcinoma: an exploratory systematic review and meta-analysis.
Non-Cochrane · prognostic · 2026 · cited as Kina 2024 · Reference list 25-34; Table 1; Fig 4-8

The review does not say which of its outcomes this study informs.

1 including review in total.